Home - Products - Angiogenesis - Bcl-2 - (22E)-Ergosta-4,6,8(14),22-tetraen-3-one

(22E)-Ergosta-4,6,8(14),22-tetraen-3-one

CAS No. 19254-69-4

(22E)-Ergosta-4,6,8(14),22-tetraen-3-one( ——— )

Catalog No. M39405 CAS No. 19254-69-4

Ergosta-4,6,8(14),22-tetraen-3-one (compound 2) is a ergosteroid is isolated from the fruiting bodies of ganoderma applanatum.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
25MG	Get Quote	In Stock
50MG	Get Quote	In Stock
100MG	Get Quote	In Stock
200MG	Get Quote	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

(22E)-Ergosta-4,6,8(14),22-tetraen-3-one
Note

Research use only, not for human use.
Brief Description

Ergosta-4,6,8(14),22-tetraen-3-one (compound 2) is a ergosteroid is isolated from the fruiting bodies of ganoderma applanatum.
Description

Ergosta-4,6,8(14),22-tetraen-3-one has cytotoxic activity against human gastric cancer cell, it can induce G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells, these results would be useful for the further utilization of many medicinal fungi in cancer treatment.
In Vitro

———
In Vivo

———
Synonyms

———
Pathway

Angiogenesis
Target

Bcl-2
Recptor

Bcl-2; p53; Caspase
Research Area

———
Indication

———

Chemical Information

CAS Number

19254-69-4
Formula Weight

392.62
Molecular Formula

C28H40O
Purity

>98% (HPLC)
Solubility

DMSO : 20 mg/mL (50.94 mM; ultraphonic; )
SMILES

———
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Gan KH, et al. Steroidal constituents of ganoderma applanatum and ganodermaneo-japonicum. J Nat Prod. 1998 Nov;61(11):1421-2.?

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Lisaftoclax

Bcl-2/Bcl-xl inhibitor 1 is a dual Bcl-2 and Bcl-xl inhibitor (IC50s: 2 nM and 5.9 nM for Bcl-2 and Bcl-xl) with anti-tumor activity. It is extracted from patent WO2018027097A1.
SW063058

SW063058 is a small molecule that selectively disrupt Beclin 1/Bcl-2 binding as compared to Bax/Bcl-2 and Bim/Bcl-2 binding and induces autophagic flux at concentrations with minimal cytotoxicity.
Thevetiaflavone

Thevetiaflavone could up-regulate the expression of Bcl 2 and down-regulate that of Bax and caspase 3.

Sign In Join Free